[Atrial fibrillation: novel possibilities of anticoagulant therapy in patients subjected to cardioversion]

MeSH terms

• Anticoagulants / administration & dosage
• Anticoagulants / adverse effects
• Anticoagulants / pharmacokinetics
• Atrial Fibrillation / complications
• Atrial Fibrillation / drug therapy*
• Atrial Fibrillation / physiopathology
• Benzimidazoles* / administration & dosage
• Benzimidazoles* / adverse effects
• Benzimidazoles* / pharmacokinetics
• Dabigatran
• Drug Monitoring / methods
• Drug Monitoring / standards
• Echocardiography, Three-Dimensional
• Electric Countershock / adverse effects*
• Humans
• International Normalized Ratio
• Premedication* / methods
• Premedication* / standards
• Randomized Controlled Trials as Topic
• Risk Adjustment
• Thromboembolism / etiology
• Thromboembolism / physiopathology
• Thromboembolism / prevention & control*
• Time Factors
• Warfarin* / administration & dosage
• Warfarin* / adverse effects
• Warfarin* / pharmacokinetics
• beta-Alanine / administration & dosage
• beta-Alanine / adverse effects
• beta-Alanine / analogs & derivatives*
• beta-Alanine / pharmacokinetics